Market Cap
$1.64 B
+$30.52 M+1.90%
49 min ago
Summary:
Celldex Therapeutics market capitalization is currently $1.64 billion, with a rise of +$30.52 million (+1.90%) during the most recent trading day. Over the past year, it has dropped by -$523.08 million (-24.23%). CLDX market cap is now -50.21% below its all-time high of $3.29 billion.CLDX Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Market Cap Performance
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | TTM Dividend per shareTTM Dividend per share |
|---|---|---|---|---|
| todaytoday | +1.9% | +1.9% | 0.0% | - |
| 1 m1 month | -8.4% | -8.4% | - | - |
| 3 m3 months | -40.5% | -40.6% | - | - |
| 6 m6 months | -31.4% | -31.8% | - | - |
| ytdytd | -26.2% | -37.8% | - | - |
| 1 y1 year | -24.2% | -37.5% | +40.4% | - |
| 5 y5 years | +4156.1% | +972.2% | +317.1% | - |
CLDX Market Cap High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $1.88 B | -13.2% | $1.57 B | +4.5% |
| 3 m | 3 months | $2.75 B | -40.5% | $1.55 B | +5.8% |
| 6 m | 6 months | $2.95 B | -44.6% | $1.55 B | +5.8% |
| 1 y | 1 year | $3.29 B | -50.2% | $1.55 B | +5.8% |
| 3 y | 3 years | $3.29 B | -50.2% | $958 M | +70.7% |
| 5 y | 5 years | $3.29 B | -50.2% | $27 M | +5905.9% |
| alltime | all time | $3.29 B | -50.2% | $16 M | >+9999.0% |
Celldex Therapeutics Market Cap History
| Date | Value |
|---|---|
| 2024 | $1.64 B(-26.2%) |
| 2023 | $2.22 B(+5.4%) |
| 2022 | $2.10 B(+16.5%) |
| 2021 | $1.81 B(+160.2%) |
| 2020 | $693.86 M(+1733.3%) |
| 2019 | $37.85 M(+5.5%) |
| 2018 | $35.87 M(-90.9%) |
| 2017 | $393.40 M(-7.8%) |
| 2016 | $426.63 M(-72.4%) |
| 2015 | $1.55 B(-5.4%) |
| 2014 | $1.64 B(-24.3%) |
| 2013 | $2.16 B(+400.3%) |
| 2012 | $431.86 M(+275.7%) |
| 2011 | $114.95 M(-13.0%) |
| 2010 | $132.07 M(-10.7%) |
| 2009 | $147.97 M(+18.3%) |
| 2008 | $125.06 M(+237.1%) |
| 2007 | $37.10 M(-62.7%) |
| 2006 | $99.40 M(-28.7%) |
| Date | Value |
|---|---|
| 2005 | $139.42 M(-6.4%) |
| 2004 | $148.99 M(-16.0%) |
| 2003 | $177.31 M(+160.1%) |
| 2002 | $68.18 M(-71.9%) |
| 2001 | $242.38 M(-38.3%) |
| 2000 | $392.91 M(+230.7%) |
| 1999 | $118.83 M(+59.7%) |
| 1998 | $74.40 M(+15.3%) |
| 1997 | $64.54 M(+99.5%) |
| 1996 | $32.35 M(-47.9%) |
| 1995 | $62.04 M(+45.6%) |
| 1994 | $42.62 M(-67.7%) |
| 1993 | $131.97 M(+33.3%) |
| 1992 | $99.03 M(-31.9%) |
| 1991 | $145.33 M(+383.1%) |
| 1990 | $30.09 M(-26.9%) |
| 1989 | $41.13 M(+150.0%) |
| 1988 | $16.45 M(-33.3%) |
| 1987 | $24.68 M(-11.1%) |
| 1986 | $27.76 M |
FAQ
- What is Celldex Therapeutics market capitalization?
- What is the all time high market cap for Celldex Therapeutics?
- What is CLDX market capitalization year-to-date change?
- What is Celldex Therapeutics market cap year-on-year change?
What is Celldex Therapeutics market capitalization?
The current market cap of CLDX is $1.64 B
What is the all time high market cap for Celldex Therapeutics?
Celldex Therapeutics all-time high market capitalization is $3.29 B
What is CLDX market capitalization year-to-date change?
Celldex Therapeutics market capitalization has changed by -$580.29 M (-26.18%) since the beginning of the year
What is Celldex Therapeutics market cap year-on-year change?
Over the past year, CLDX market capitalization has changed by -$523.08 M (-24.23%)